• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[청년의사][바이오USA 2024] 큐로셀 “해외 법인 설립 검토” 

2024/06/10

[바이오USA 2024] 큐로셀 “해외 법인 설립 검토”  < [바이오USA 2024] < 기획·특집 < 기사본문 – 청년의사 (docdocdoc.co.kr)

Prev큐로셀, 차세대 CAR-T 치료제 ‘안발셀’ 최종 임상시험보고서 수령
Next[머니투데이] 큐로셀 “안발셀, 킴리아 넘는 차세대 CAR-T 치료제 자신”
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.